Axsome Therapeutics develops and sells medicines for depression, sleep disorders and migraine, with its headquarters in New York. It last closed at $135.95 on Nov 17, down 0.77% on the day. AXSM last reported earnings on Mon, Aug 10, 2026. The average 12-month price target from 10 analysts is $255.70 (+88.1% from the last close), with a high of $290.00 and a low of $220.00. Analyst consensus is Strong Buy, based on the latest ratings from 10 firms (9 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in AXSM, 0% of them bullish and 100% bearish. In the past 30 days there were 1 dark pool print totaling $949K, the largest $949K.
Each firm's latest rating on AXSM in the past 90 days
Average 12-month target
$255.70
▲ 88.1% upside
Based on 10 analysts who set a price target on AXSM in the past 90 days. The average target is $255.70, with a high of $290.00 and a low of $220.00, compared with the last close of $135.95.
Low $220.00Avg $255.70High $290.00
Blue marker: last close $135.95
Highest target$290.00
Average target$255.70
Lowest target$220.00
Latest rating changes
Morgan StanleyTarget lowered
Nov 13Hold$249 → $223
MizuhoTarget lowered
Nov 4Buy$316 → $272
Morgan StanleyTarget raised
Nov 3Hold$247 → $249
UBSMaintained
Nov 3Buy$239
RBC CapitalTarget lowered
Nov 3Buy$295 → $273
Date
Firm
Action
Rating
Price target
Nov 13
Morgan Stanley
Target lowered
Hold
$249 → $223
Nov 4
Mizuho
Target lowered
Buy
$316 → $272
Nov 3
Morgan Stanley
Target raised
Hold
$247 → $249
Nov 3
UBS
Maintained
Buy
$239
Nov 3
RBC Capital
Target lowered
Buy
$295 → $273
Loading…
Technical Analysis
AXSM · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 4% below its 20 day and 24% below its 50 day average. It is 45% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 37), near oversold. The nearest support is the Pivot S1 at $134.58, and the nearest resistance the Pivot at $136.04.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 5.3%/day
Key levels
$260.1952 week high+91.4%
$196.56200 day average+44.6%
$195.85100 day average+44.1%
$168.6250 day average+24.0%
$147.49Swing high (Oct 29)+8.5%
$141.6520 day average+4.2%
$137.41Pivot R1+1.1%
$136.04Pivot+0.1%
$135.95Last close
$134.58Pivot S1−1.0%
$123.0252 week low−9.5%
$123.02Swing low (Nov 2)−9.5%
Indicators
RSI (14)
36.63
Weak, oversold below 30
Neutral
MACD
-7.93
Above its signal line
Bullish
Stochastic
53.7
Middle of its range
Neutral
ADX (14)
34.9
Trending down
Williams %R
-54.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-68.0
Oversold below −100, overbought above 100
Neutral
Rate of change
−2.6%
Change over 10 sessions
Bearish
ATR (14)
$7.24
Typical daily range, 5.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 12.8%/day
Key levels
$260.1952 week high+91.4%
$196.56200 day average+44.6%
$195.85100 day average+44.1%
$168.6250 day average+24.0%
$147.49Swing high (Oct 29)+8.5%
$141.6520 day average+4.2%
$137.41Pivot R1+1.1%
$136.04Pivot+0.1%
$135.95Last close
$134.58Pivot S1−1.0%
$123.0252 week low−9.5%
$123.02Swing low (Nov 2)−9.5%
Indicators
RSI (14)
30.82
Weak, oversold below 30
Neutral
MACD
-17.64
Below its signal line
Bearish
Stochastic
12.8
Near the bottom of its range
Oversold
ADX (14)
28.7
Trending down
Williams %R
-87.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-116.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−38.4%
Change over 10 sessions
Bearish
ATR (14)
$17.45
Typical daily range, 12.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for AXSM
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how AXSM did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow AXSM usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How AXSM has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AXSM is in one of them and how their past AXSM trades turned out.
Axsome Therapeutics is a biopharmaceutical company based in New York that develops medicines for disorders of the central nervous system. Its approved products treat major depressive disorder, excessive daytime sleepiness linked to sleep apnea or narcolepsy, and acute migraine in adults. The company markets these medicines to patients and prescribing doctors, and it is developing further treatments, including one for agitation linked to Alzheimer's disease.